CLINICAL EVALUATION OF EFFICACY AND TOLERABILITY OF ANTROLIN RETTAL CREME IN THE TREATMENT OF POSTHEMORROIDECTOMY PAIN. DUOBLE BLIND STUDY

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-003514-15-IT

Enrollment

260

Registered

2006-03-14

Start date

2005-11-03

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pOST-HEMORROIDECTOMY PAIN MedDRA version: 6.1 Level: PT Classification code 10019022

Interventions

Trade Name: ANTROLIN 0,3 1,5 CR 300G Pharmaceutical Form: Rectal cream INN or Proposed INN: Other preparations, combinations Concentration unit: g gram(s) Concentration type: equal Concentration numb

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026